Quantum-Si to Participate in the 41st Annual J.P. Morgan Healthcare Conference

GUILFORD, Conn.–(BUSINESS WIRE)– Dec. 22, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference taking place at the Westin St. Francis, San Francisco, CA on January 9-12, 2023.

Quantum-Si’s management will present on Thursday, January 12 at 10:30 am Pacific Standard Time. The discussions will cover recent company developments, including the recently-announced commercial availability of Quantum-Si’s groundbreaking Platinum™ instrument, which is the first system to enable next-generation, single-molecule protein sequencing.

A live and archived webcast of the events will be available in the Investors section of the Quantum-Si website under Events & Presentations.

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantumsi.supremeclients.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221222005515/en/

Investor Contact
Juan Avendano
[email protected]

Media Contact
Michael Sullivan
[email protected]

Source: Quantum-Si Incorporated